Historical record - last NADAC publication: 6/21/2023
Product Information
QC ASPIRIN 325 MG TABLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0121 per EA under NDC 63868035203. Its NADAC has been published 501 times since Nov 28, 2013.
Strength
325 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
63868035203
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/21/2023
Active Ingredients
ASPIRINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
2/10/1996
Pharmacological Classes
Price Statistics
The NADAC for QC ASPIRIN 325 MG TABLET has been published 501 times since Nov 28, 2013, and over the history we have for it it has risen 26.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0121 per EA |
|---|---|
| All-time high | $0.0136 (Apr 12, 2023) |
| All-time low | $0.0091 (May 19, 2021) |
| Median price | $0.0102 |
| Average price | $0.0104 |
| Largest weekly change | -18.8% (Apr 19, 2023) |
| Weeks tracked | 501 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QC ASPIRIN 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QC ASPIRIN 325 MG TABLET, manufactured by Chain Drug Marketing Association, is $0.0121 per EA (NDC 63868035203), effective Jun 28, 2023.
How has the price of QC ASPIRIN 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for QC ASPIRIN 325 MG TABLET has risen 26.7%. It has been tracked across 501 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QC ASPIRIN 325 MG TABLET?
Since Nov 28, 2013, the NADAC for QC ASPIRIN 325 MG TABLET has ranged from a low of $0.0091 (May 19, 2021) to a high of $0.0136 (Apr 12, 2023), with a median of $0.0102 per EA.
Are there cheaper alternatives to QC ASPIRIN 325 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as QC ASPIRIN 325 MG TABLET, but none are currently priced below it.
Who manufactures QC ASPIRIN 325 MG TABLET?
QC ASPIRIN 325 MG TABLET (NDC 63868035203) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification